Previous studies have shown that Sushi Repeat Containing Protein X-linked 2 (SRPX2) acts as a tumor-promoting factor in various cancers [93–95], and the down-regulation of SRPX2 can improve the sensitivity of esophageal cancer patients to cisplatin [96]. The gene discussed is SRPX2; the disease is cancer.